Improved cell lines having reduced expression of NOCR and use thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- BOEHRINGER INGELHEIM INT GMBH
- Publication Date
- 2012-04-11
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
Technical field
[0001] The present invention relates to the field of cell culture technology. It is about a production host cell line with increased expression of ribosomal RNA (rRNA). This increase is achieved by reducing the expression of NoCR protein (especially TIP-5). These cell lines have improved secretion and growth characteristics than control cell lines. Background of the invention
[0002] Screening out mammalian cell lines for efficient producers remains a major challenge in the biomedical manufacturing industry. The process from DNA to product translation is the main bottleneck that limits the specific productivity of mammalian production cell lines. Cells can up-regulate the rate of protein synthesis by increasing the translation efficiency of existing ribosomes or by generating new ribosomes (ribosome biosynthesis). Since about 80% of the total nuclear transcription is used to synthesize ribosomal RNA (rRNA), ribosomal biosynthesis is one of the main metabolic a...